Glycogen synthase kinase-3β inhibition of 6-(methylsulfinyl)hexyl isothiocyanate derived from wasabi (Wasabia japonica Matsum). (Q54620476)

1 June 2018

title

Glycogen synthase kinase-3β inhibition of 6-(methylsulfinyl)hexyl isothiocyanate derived from wasabi (Wasabia japonica Matsum). (English)

1 reference

1 June 2018

main subject

Wasabia japonica

object named as

Wasabia japonica

1 reference

Jun Yoshida

1

1 reference

1 June 2018

Satomi Nomura

2

1 reference

1 June 2018

Naoyuki Nishizawa

3

1 reference

1 June 2018

Yoshiaki Ito

4

1 reference

1 June 2018

Ken-ichi Kimura

5

1 reference

1 June 2018

publication date

7 January 2011

1 reference

1 June 2018

Bioscience, Biotechnology, and Biochemistry

published in

1 reference

1 June 2018

volume

75

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

page(s)

136-139

1 reference

1 June 2018

Selective sensitivity to wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate of human breast cancer and melanoma cell lines studied in vitro.

cites work

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-activated murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

Inhibition of lipopolysaccharide-induced cyclooxygenase-2 transcription by 6-(methylsulfinyl) hexyl isothiocyanate, a chemopreventive compound from Wasabia japonica (Miq.) Matsumura, in mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

Glycogen Synthase Kinase-3 from Rabbit Skeletal Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

Physiological roles of calcineurin in Saccharomyces cerevisiae with special emphasis on its roles in G2/M cell-cycle regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

New eremophilane sesquiterpenoid compounds, eremoxylarins A and B directly inhibit calcineurin in a manner independent of immunophilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

Detection of 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) and its conjugate with N-acetyl-L-cysteine (NAC) by high performance liquid chromatograpy-atmospheric pressure chemical ionization mass spectrometry (HPLC-MS/APCI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

Yeast glycogen synthase kinase-3 activates Msn2p-dependent transcription of stress responsive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1271%2FBBB.100507

21 January 2018

Identifiers

DOI

10.1271/BBB.100507

1 reference

1 June 2018

1 reference

1 June 2018